You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The Harvard University spinout uses a combination of proprietary probes, nanoarrays, and convection PCR to target a broad set of molecular biomarkers.
The percentage of perfectly modified alleles using the new base editor is more than 6,000-fold for disease correction compared with the current BE4max editor.
The technologies, called non-extensible oligonucleotides and linear DNA assembly, may help the sample prep firm improve existing products.
A new analysis pointed to a rise in over-generalized or incorrect bacterial identification by k-mer lowest common ancestor methods as the database has grown.
In PNAS this week: three-dimensional chromosome structure, ovarian cancer immunopeptidome, and more.
In Genome Biology this week: computational approach for analyzing noisy single-cell sequencing profiles, eQTLs of dilated cardiomyopathy, and more.
In Nature this week: multi-omic neuroscience quantitative trait locus resource, and more.
Researchers used the approach to develop an assay to detect above-threshold triplet repeats in Huntington's disease, but also highlight a variety of other applications.
The Rice University researchers identified 11 pathogenic bacteria strains using only five randomly selected DNA probes.
A report calls on the next US president to keep both the White House science office and the position of science adviser, ScienceInsider says.
Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.
A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.
In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.
According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.